Carvone / Catalase Cancer Research Results

CRV, Carvone: Click to Expand ⟱
Features:

Carvone — Carvone is a chiral oxygenated monocyclic monoterpene ketone found mainly as enantiomeric forms in spearmint, caraway, dill, and related essential oils. It is best classified as a small-molecule natural product / volatile terpenoid flavor-fragrance compound, commonly abbreviated CRV. The biologically relevant forms are often reported as l-carvone, d-carvone, R-carvone, or S-carvone, but naming conventions are inconsistent across papers, so note the exact enantiomer stated by each source.

Primary mechanisms (ranked):

  1. Induction of cancer-cell apoptosis through p53, Bad, caspase-3 activation, PARP cleavage, and DNA-damage-associated stress signaling.
  2. Suppression of migration, adhesion, invasion, and metastatic behavior, especially through FAK-related signaling in breast cancer models.
  3. Context-dependent oxidative stress modulation, including ROS increase and DNA damage at cytotoxic in-vitro concentrations.
  4. Inhibition of proliferative survival pathways, including JAK/STAT3 in gastric cancer and p38 MAPK-related signaling in myeloma models.
  5. Cell-cycle disruption, reported as S-phase, G0/G1, or G2/M arrest depending on enantiomer, cancer model, and concentration.
  6. Possible chemopreventive activity in animal skin-carcinogenesis models, but not established as a clinically validated anticancer agent.

Bioavailability / PK relevance: Carvone is lipophilic and volatile, with oral, dermal, and inhalational exposure relevance depending on formulation. Human PK/metabolism data exist for ingestion-correlated and topical/percutaneous exposure contexts, but anticancer studies generally use concentrations that are not directly matched to validated systemic anticancer exposure. Essential-oil delivery introduces variability from enantiomer ratio, co-terpenes, oxidation products, and formulation.

In-vitro vs systemic exposure relevance: Common anticancer in-vitro effects occur at high micromolar to millimolar or microgram-per-millilitre ranges, and breast-cancer IC50 values around the millimolar range have been reported. These levels are likely above ordinary dietary flavor exposure and may exceed practical systemic exposure from food-like intake. Interpretation should therefore be concentration-constrained and formulation-dependent.

Clinical evidence status: Preclinical for cancer. Evidence includes cancer cell-line studies, animal chemoprevention/tumor models, and mechanistic studies, but no credible cancer RCTs of carvone as a therapeutic agent were identified. Human studies involving carvone-containing preparations exist for non-cancer indications or mixtures, but they should not be treated as direct anticancer evidence for isolated carvone.

Safety / regulatory status: Carvone is listed as a FEMA GRAS flavoring substance with CFR flavor-use reference, but this applies to intended flavor-use exposure, not therapeutic dosing. Major constraints include skin sensitization potential, enantiomer/formulation variability, volatile exposure, and uncertain safety at high supplemental or pharmacologic doses. Fragrance safety assessment data indicate no genotoxic concern under reviewed conditions, but l-carvone is considered a skin sensitizer.

Carvone Mechanistic Profile

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 Apoptosis execution ↑ p53, ↑ Bad, ↑ cleaved caspase-3, ↑ cleaved PARP Lower sensitivity reported in some normal-cell comparisons G Pro-apoptotic cytotoxicity Most central anticancer mechanism; strongest evidence is in vitro and concentration-dependent.
2 Migration adhesion invasion ↓ migration, ↓ adhesion, ↓ invasion, ↓ FAK activation Not well-defined G Anti-metastatic phenotype Mechanistically important for breast cancer models; therapeutic leverage is plausible but not clinically validated.
3 ROS and DNA damage stress ↑ ROS, ↑ DNA damage markers, ↑ apoptotic stress Context-dependent antioxidant or cytoprotective effects reported outside cancer R/G Stress-mediated apoptosis ROS appears pro-apoptotic in several cancer contexts; antioxidant effects in non-cancer models make this axis context-dependent.
4 JAK STAT3 survival signaling ↓ JAK/STAT3 signaling in gastric cancer models Not well-defined G Reduced survival signaling Promising but model-specific; should not be generalized across all tumor types without direct evidence.
5 p38 MAPK signaling ↓ p38 MAPK-related signaling in myeloma models Not well-defined G Growth and invasion suppression Reported in myeloma; secondary/contextual relative to apoptosis and motility effects.
6 Cell cycle control ↑ arrest at S, G0/G1, or G2/M depending on model Not well-defined G Reduced proliferation Direction of arrest is inconsistent across cancer systems and enantiomer reports; keep model-specific.
7 Mitochondrial apoptosis ↓ mitochondrial membrane potential reported in some models, ↑ caspase-linked apoptosis Context-dependent R/G Intrinsic apoptosis support Relevant when mitochondrial depolarization or ROS-mediated apoptosis is directly measured.
8 Angiogenesis tumor microenvironment ↓ angiogenesis stimulus in Ehrlich tumor context Not well-defined G Reduced tumor support phenotype Evidence is less mature than direct cancer-cell apoptosis and migration data.
9 NRF2 redox adaptation ↔ or uncertain Possible cytoprotective relevance in oxidative stress models G Unresolved redox adaptation
10 Clinical Translation Constraint High in-vitro concentrations may not map to achievable systemic exposure Skin sensitization and exposure-route constraints G Limits translational confidence Bioavailability, enantiomer identity, essential-oil composition, and flavor-use versus therapeutic-dose safety are the main constraints.

P: 0–30 min R: 30 min–3 hr G: >3 hr
Catalase, Catalase: Click to Expand ⟱
Source:
Type:
Caspases are a cysteine protease that speed up a chemical reaction via pointing their target substrates following an aspartic acid residue.1 They are grouped into apoptotic (caspase-2, 3, 6, 7, 8, 9 and 10) and inflammatory (caspase-1, 4, 5, 11 and 12) mediated caspases.
Caspase-1 may have both tumorigenic or antitumorigenic effects on cancer development and progression, but it depends on the type of inflammasome, methodology, and cancer.
Catalase is an enzyme found in nearly all living cells exposed to oxygen. Its primary role is to protect cells from oxidative damage by catalyzing the conversion of hydrogen peroxide (H₂O₂), a potentially damaging byproduct of metabolism, into water (H₂O) and oxygen (O₂). This detoxification process is crucial because excess H₂O₂ can lead to the formation of reactive oxygen species (ROS) that damage proteins, lipids, and DNA.

Catalase and Cancer
Oxidative Stress and Cancer:
Cancer cells often experience increased levels of oxidative stress due to rapid proliferation and metabolic changes. This stress can lead to DNA damage, promoting tumorigenesis.
Catalase helps mitigate oxidative stress, and its expression can influence the survival and proliferation of cancer cells.
Expression Levels in Different Cancers:
Overexpression: In some cancers, such as breast cancer and certain types of leukemia, catalase may be overexpressed. This overexpression can help cancer cells survive in oxidative environments, potentially leading to more aggressive tumor behavior.
Downregulation: Conversely, in other cancers, such as colorectal cancer, reduced catalase expression has been observed. This downregulation can lead to increased oxidative stress, contributing to tumor progression and metastasis.
Prognostic Implications:
Survival Rates: Studies have shown that high levels of catalase expression can be associated with poor prognosis in certain cancers, as it may enable cancer cells to resist apoptosis (programmed cell death) induced by oxidative stress.

Some types of cancer cells have been reported to exhibit lower catalase activity, possibly increasing their vulnerability to oxidative damage under certain conditions. This vulnerability has even been exploited in some therapeutic strategies (for example, approaches that generate excess H₂O₂ or other ROS specifically targeting cancer cells have been researched).
Scientific Papers found: Click to Expand⟱
6525- CRV,    D-carvone induced ROS mediated apoptotic cell death in human leukemic cell lines (Molt-4)
- in-vitro, AML, NA
tumCV↓, ROS↑, antiOx↓, MMP↓, Apoptosis↑, Casp8↑, Casp9↑, Casp3↑, *neuroP↑, AntiCan↑, *AntiArt↑, TBARS↑, SOD↓, GSH↓, Catalase↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

antiOx↓, 1,   Catalase↓, 1,   GSH↓, 1,   ROS↑, 1,   SOD↓, 1,   TBARS↑, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Cell Death ⓘ

Apoptosis↑, 1,   Casp3↑, 1,   Casp8↑, 1,   Casp9↑, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Functional Outcomes ⓘ

AntiCan↑, 1,  
Total Targets: 13

Pathway results for Effect on Normal Cells:


NA, unassigned ⓘ

AntiArt↑, 1,  

Functional Outcomes ⓘ

neuroP↑, 1,  
Total Targets: 2

Scientific Paper Hit Count for: Catalase, Catalase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:411  Target#:46  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page